Home
Live Updates
Serdexmethylphenidate Granted Orphan Drug Status for Idiopathic Hypersomnia : vimarsana.com
Serdexmethylphenidate Granted Orphan Drug Status for Idiopathic Hypersomnia
The FDA has granted Orphan Drug designation to serdexmethylphenidate (KP1077) for the treatment of idiopathic hypersomnia.
Related Keywords
Travis Mickle ,
Drug Administration ,
Orphan Drug ,
vimarsana.com © 2020. All Rights Reserved.